Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Denali Therapeutics (DNLI) Return on Assets (2018 - 2025)

Historic Return on Assets for Denali Therapeutics (DNLI) over the last 8 years, with Q3 2025 value amounting to 0.1%.

  • Denali Therapeutics' Return on Assets rose 1900.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.33% for FY2024, which is 2200.0% down from last year.
  • Denali Therapeutics' Return on Assets amounted to 0.1% in Q3 2025, which was up 1900.0% from 0.18% recorded in Q2 2025.
  • Denali Therapeutics' 5-year Return on Assets high stood at 0.04% for Q1 2021, and its period low was 0.3% during Q4 2024.
  • In the last 5 years, Denali Therapeutics' Return on Assets had a median value of 0.2% in 2021 and averaged 0.16%.
  • Data for Denali Therapeutics' Return on Assets shows a peak YoY increase of 3800bps (in 2021) and a maximum YoY decrease of -2600bps (in 2021) over the last 5 years.
  • Denali Therapeutics' Return on Assets (Quarter) stood at 0.2% in 2021, then fell by -20bps to 0.24% in 2022, then soared by 50bps to 0.12% in 2023, then tumbled by -146bps to 0.3% in 2024, then soared by 65bps to 0.1% in 2025.
  • Its Return on Assets was 0.1% in Q3 2025, compared to 0.18% in Q2 2025 and 0.24% in Q1 2025.